ボディコントゥアリング装置市場 – 2029年までの世界予測

The body contouring devices market is projected to reach USD 3.00 Billion by 2029 from USD 1.74 Billion in 2024, at a CAGR of 11.4% during the forecast period.

ボディコントゥアリング装置市場は、予測期間中のCAGR 11.4%で、2024年の17.4億米ドルから2029年までに30億米ドルに達すると予測されています。

Market expansion is propelled by factors such as the growing utilization of non-invasive body contouring devices, increase in the advertisement of aesthetic procedures on social media and easily accessible clinics andbeauty centers for these procedures. Conversely, significant market consolidation among key players and the need for substantial capital investments pose notable obstacles to market growth.

“Non-invasive segment accounted for the highest CAGR.”

By product, the market is primarily segmented into non-invasive and invasive. The non-invasive segment accounted for the highest growth rate of the body contouring devices in 2023. The substantial increase in market growth can be primarily attributed to the extensive utilization of both non-invasive and  minimally invasive body contouring devices. Furthermore, advancements in the technology of application such as fat reduction and body tonning instruments and the growing demand for aesthetic and plastic surgeries are driving the expansion of this sector.

“The fat reduction segment accounted for the market share in the body contouring devices market, byapplication, during the forecast period.”

Byapplication, the market is primarily segmented into body toning and sculpting, fat reduction, cellulite treatment and skin tighteing. In 2023, non-robotic surgery accounted for the highest share of this market. The main factors propelling the growth of the market are the cost effective procedures for fat reduction, increase use of technologies like radiofrequency and lasers that provides least risk risingmiddle aged population. Additionally, surgeons preference of fat reduction devices over the slow weight loss process, contributing to their continued prominence in the market.

“Between 35 to 50 years segment accounted for the highest growth rate.”

By age group , the market is primarily segmented into between 35to 50 years, above 50 years and below 35 years . The between 30 to 50 years segment accounted for the highest growth rate of the body contouring devices age group market in 2023. The primary drivers of growth in this market are increase in obese population among the middle age population, increase competition among this age group population to look aesthetic and increase in advertisement of the body contouring procedures over social media.

“Female segment accounted for the largest market share.”

By gender , the market is primarily segmented into female and male . The female segment accounted for the highest share of the body contouring devices gender market in 2023. Easy accessibility of the body contouring devices and procedures, increased adoption of the body changes by female for aesthetic appearance and improved technologically advanced procedures with lowest downtime are the major reasons attributing to the largest share of the gender body contouring devices market.

“Specialty clinics segment accounted for the highest share.”

By end user, the market is primarily segmented into hospitals, specialty clinics and medical spas and beauty centers. The specialty clinics segment accounted for a larger share of the body contouring devices market in 2023. This can be credited to the significant volume of non-invasive surgical procedures carried out inspecialty clinics, facilitated by the presence of highly skilled healthcare professionals.

“Asia Pacific: The fastest-growing region in body contouring devices market.”

The global body contouring devices market is segmented into North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa and GCC Countries. Various factors are contributing to the growth of the market in the Asia-Pacific (APAC) region, including escalating healthcare expenditure, increase in medical tourism in the regions like China, India, Vietnam, rising per capita income, expansion of private-sector healthcare facilities into rural areas across several APAC nations and the existence of high-growth markets in the region. Moreover, the advantageous regulatory landscape and low costs in this region are anticipated to further drive market expansion.

Breakdown of supply-side primary interviews, by company type, designation, and region:

• By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (42%), Europe (31%), Asia- Pacific (20%), Latin America (4%), Middle East & Africa(2%) and GCC Countries (1%)

Lists of Companies Profiled in the Report:

• Abbvie, Inc. (US)
• Cutera (US)
• Bausch Health Companies Inc. (Canada)
• InMode Ltd. (Israel)
• Venus Concept (Canada)
• ENDYMED Medical (US)
• Cynosure Lutronic (US)
• Lumenis BE Ltd. (Israel)
• Alma Lasers (Israel)
• Candela Corporation (US)
• BTL Aesthetics Ltd. (UK)
• MicroAire Surgical Instruments LLC (US)
• Fotona (Slovenia)
• Nouvag AG (Switzerland)
• Erchonia Corporation (US)
• Konmison (China)
• Skinnovation Pvt. Ltd. (India)
• 3D Aesthetics (UK)
• Zimmer MedizinSystems Gmbh (Germany)
• Rohrer Aesthetics (US)
• Skin Aesthetics (India)
• SharpLight Technologies Inc. (Israel)
• Sebbin (France)
• Deka M.E.L.A. S.R.L. (Italy)
• INDIBA (Spain)

Research Coverage

This research report categorizes the body contouring devices market by product, application, age group, gender, end-user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the body contouring devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview; key strategies; product launch, approval, acquisition, merger and recent developments associated with the body contouring devices market. Competitive analysis of upcoming startups in the body contouring devices market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall body contouring devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

Analysis of key drivers (Growing adoption of minimally invasive and noninvasive aesthetic procedures), restraints (High cost of treatment and lack of reimbursement), opportunities (Improving healthcare infrastructure in emerging markets), and challenges (Stringent regulatory compliance and safety standards) influencing the growth of the body contouring devices market.

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the body contouring devices market
• Market Development: Comprehensive information about lucrative markets – the report analyses the body contouring devices market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the body contouring devices market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Abbvie, Inc. (US), Cutera (US), Bausch Health Companies Inc. (Canada), InMode Ltd. (Israel), Venus Concept (Canada) among others in body contouring devices market.

Table of Contents

1            INTRODUCTION            29

1.1         STUDY OBJECTIVES      29

1.2         MARKET DEFINITION   29

1.3         INCLUSIONS & EXCLUSIONS     30

1.4         STUDY SCOPE  31

1.4.1      BODY CONTOURING DEVICES MARKET             31

1.4.2      YEARS CONSIDERED     32

1.4.3      CURRENCY CONSIDERED          32

1.5         MARKET STAKEHOLDERS          32

2            RESEARCH METHODOLOGY     33

2.1         RESEARCH DATA           33

2.1.1      SECONDARY DATA       34

2.1.1.1   Key data from secondary sources     34

2.1.2      PRIMARY DATA 35

2.1.2.1   Primary sources   36

2.1.2.2   Key data from primary sources         36

2.1.2.3   Key industry insights          37

2.1.2.4   Breakdown of primary interviews     38

2.2         MARKET SIZE ESTIMATION       39

2.2.1      BOTTOM-UP APPROACH           39

2.2.1.1   Approach 1: Company revenue estimation approach    39

2.2.1.2   Approach 2: Presentations of companies and primary interviews              40

2.2.1.3   CAGR projections             40

2.2.2      TOP-DOWN APPROACH             40

2.3         MARKET BREAKDOWN & DATA TRIANGULATION          42

2.4         MARKET SHARE ESTIMATION   43

2.5         ASSUMPTIONS & LIMITATIONS 43

2.5.1      GROWTH RATE ASSUMPTIONS 43

2.5.2      LIMITATIONS   44

2.6         RISK ASSESSMENT         44

3            EXECUTIVE SUMMARY 45

4            PREMIUM INSIGHTS      50

4.1         BODY CONTOURING DEVICES MARKET OVERVIEW      50

4.2         BODY CONTOURING DEVICES MARKET SHARE, BY TYPE, 2024 VS. 2029              51

4.3         BODY CONTOURING DEVICES MARKET SHARE, BY APPLICATION, 2024 VS. 2029 51

4.4         BODY CONTOURING DEVICES MARKET SHARE, BY AGE GROUP, 2024 VS. 2029 52

4.5         BODY CONTOURING DEVICES MARKET SHARE, BY GENDER, 2024 VS. 2029      53

4.6         BODY CONTOURING DEVICES MARKET SHARE, BY END USER, 2024 VS. 2029      53

4.7         BODY CONTOURING DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES           54

5            MARKET OVERVIEW     55

5.1         INTRODUCTION            55

5.2         MARKET DYNAMICS     55

5.2.1      DRIVERS            56

5.2.1.1   Growing adoption of minimally invasive and non-invasive aesthetic procedures              56

5.2.1.2   Increasing awareness and acceptance of body contouring           57

5.2.1.3   Increasing demand for aesthetic treatments among men            58

5.2.1.4   Technological advancements           58

5.2.2      RESTRAINTS     59

5.2.2.1   High cost of treatment and lack of reimbursement       59

5.2.3      OPPORTUNITIES           60

5.2.3.1   Improving healthcare infrastructure in emerging markets          60

5.2.4      CHALLENGES   61

5.2.4.1   Stringent regulatory compliance and safety standards  61

5.2.4.2   Social and cultural barriers in emerging economies      62

5.3         PRICING ANALYSIS        62

5.3.1      INDICATIVE PRICING MODEL ANALYSIS OF MARKET PLAYERS 62

5.3.2      AVERAGE SELLING PRICE OF BODY CONTOURING DEVICES, BY REGION             63

5.4         PATENT ANALYSIS        65

5.4.1      LIST OF MAJOR PATENTS          66

5.5         VALUE CHAIN ANALYSIS            66

5.6         SUPPLY CHAIN ANALYSIS          68

5.7         TRADE ANALYSIS          69

5.7.1      TRADE ANALYSIS FOR LASER AESTHETIC DEVICES        69

5.8         ECOSYSTEM ANALYSIS 70

5.8.1      BODY CONTOURING DEVICES MARKET: ROLE IN ECOSYSTEM 71

5.9         PORTER’S FIVE FORCES ANALYSIS         72

5.9.1      THREAT OF NEW ENTRANTS    73

5.9.2      THREAT OF SUBSTITUTES         73

5.9.3      BARGAINING POWER OF BUYERS           73

5.9.4      BARGAINING POWER OF SUPPLIERS     73

5.9.5      INTENSITY OF COMPETITIVE RIVALRY 73

5.10       REGULATORY LANDSCAPE       73

5.10.1    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          74

5.10.2    REGULATORY ANALYSIS            75

5.10.2.1 North America     75

5.10.2.1.1            US         75

5.10.2.1.2            Canada  76

5.10.2.2 Europe  76

5.10.2.3 Asia Pacific          77

5.10.2.3.1            China     77

5.10.2.3.2            Japan     78

5.10.2.3.3            India      78

5.10.2.4 Latin America      78

5.10.2.4.1            Brazil     78

5.10.2.4.2            Mexico  79

5.10.2.5 Middle East         79

5.11       TECHNOLOGY ANALYSIS           80

5.11.1    KEY TECHNOLOGIES    80

5.11.1.1 Cryolipolysis        80

5.11.1.2 Radiofrequency (RF)         80

5.11.1.3 High-intensity-focused Ultrasound (HIFU)   80

5.11.2    COMPLEMENTARY TECHNOLOGIES     80

5.11.2.1 Laser-assisted devices        80

5.11.2.2 Implants 80

5.11.3    ADJACENT TECHNOLOGIES      80

5.11.3.1 Body sculpting rollers        80

5.11.3.2 Electrostimulation devices 80

5.12       KEY CONFERENCES & EVENTS IN 2024–2025       81

5.13       TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81

5.13.1    TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82

5.14       KEY STAKEHOLDERS & BUYING CRITERIA          82

5.14.1    KEY STAKEHOLDERS IN BUYING PROCESS         82

5.14.2    BUYING CRITERIA         84

5.15       INVESTMENT & FUNDING SCENARIO    85

5.16       IMPACT OF AI ON BODY CONTOURING DEVICES MARKET        85

6            BODY CONTOURING DEVICES MARKET, BY TYPE          86

6.1         INTRODUCTION            87

6.2         NON-INVASIVE DEVICES            87

6.2.1      RADIOFREQUENCY (RF) DEVICES          91

6.2.1.1   Ability to deliver noticeable results with minimal downtime to drive market growth              91

6.2.2      CRYOLIPOLYSIS/FAT FREEZING DEVICES          94

6.2.2.1   Risk associated with fat freezing to challenge market growth      94

6.2.3      HIGH-INTENSITY-FOCUSED ULTRASOUND (HIFU) DEVICES     97

6.2.3.1   Minimal downtime of HIFU devices to support adoption           97

6.2.4      LOW-LEVEL LASER THERAPY (LLLT) DEVICES  100

6.2.4.1   Increased patient safety and quick results to support market growth        100

6.2.5      OTHER NON-INVASIVE DEVICES            103

6.3         INVASIVE DEVICES        106

6.3.1      LIPOSUCTION DEVICES             109

6.3.1.1   Increasing obese population to drive growth  109

6.3.2      LASER-ASSISTED DEVICES         114

6.3.2.1   Shift towards minimally invasive aesthetic treatments to drive growth      114

6.3.3      IMPLANTS/FILLERS      117

6.3.3.1   Rising demand for cosmetic implants to fuel growth     117

7            BODY CONTOURING DEVICES MARKET, BY APPLICATION        121

7.1         INTRODUCTION            122

7.2         FAT REDUCTION           122

7.2.1      INCREASING NUMBER OF NON-INVASIVE AND MINIMALLY INVASIVE AESTHETIC PROCEDURES TO PROPEL MARKET GROWTH         122

7.3         SKIN TIGHTENING        125

7.3.1      INTRODUCTION OF CUTTING-EDGE DEVICES TO FUEL UPTAKE              125

7.4         BODY TONING & SCULPTING   128

7.4.1      INCREASED CONSUMER DESIRE FOR ENHANCED BODY AESTHETICS TO DRIVE MARKET GROWTH   128

7.5         CELLULITE TREATMENT           131

7.5.1      ADVANTAGES ASSOCIATED WITH ROBOTIC-ASSISTED SURGERY TO BOOST MARKET GROWTH        131

8            BODY CONTOURING DEVICES MARKET, BY AGE GROUP            135

8.1         INTRODUCTION            136

8.2         BETWEEN 35 TO 50 YEARS         136

8.2.1      GROWING INTEREST IN MAINTAINING YOUTHFUL APPEARANCE TO DRIVE MARKET GROWTH          136

8.3         ABOVE 50 YEARS            139

8.3.1      GROWING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN ACCEPTANCE OF COSMETIC PROCEDURES TO BOOST MARKET            139

8.4         BELOW 35 YEARS           142

8.4.1      INCREASING NUMBER OF CUSTOMIZABLE TREATMENT PLANS TO FAVOR MARKET GROWTH        142

9            BODY CONTOURING DEVICES MARKET, BY GENDER    146

9.1         INTRODUCTION            147

9.2         WOMEN             147

9.2.1      INCREASED AWARENESS AND ACCESSIBILITY OF BODY CONTOURING PROCEDURES TO DRIVE MARKET GROWTH     147

9.3         MEN     150

9.3.1      INCREASING ACCEPTANCE OF AESTHETIC PROCEDURES AMONG MEN TO BOOST UPTAKE           150

10          BODY CONTOURING DEVICES MARKET, BY END USER 154

10.1       INTRODUCTION            155

10.2       SPECIALTY CLINICS      155

10.2.1    OPERATIONAL ENHANCEMENTS, COMBINED WITH TARGETED MARKETING STRATEGIES, TO PROPEL MARKET            155

10.3       MEDICAL SPAS & BEAUTY CENTERS      158

10.3.1    AVAILABILITY OF MEDICAL TREATMENT IN COMFORTABLE AND RELAXING SETTINGS TO AID MARKET GROWTH           158

10.4       HOSPITALS       161

10.4.1    GROWING ADOPTION OF MINIMALLY INVASIVE PROCEDURES IN HOSPITALS TO SUPPORT MARKET GROWTH    161

11          BODY CONTOURING DEVICES MARKET, BY REGION     165

11.1       INTRODUCTION            166

11.2       NORTH AMERICA          166

11.2.1    MACROECONOMIC OUTLOOK FOR NORTH AMERICA   171

11.2.2    US         172

11.2.2.1 Increased demand for aesthetic procedures to drive market growth          172

11.2.3    CANADA            175

11.2.3.1 Rapid increase in geriatric population and increased awareness about non-invasive body contouring procedures to boost market  175

11.3       EUROPE             179

11.3.1    MACROECONOMIC OUTLOOK FOR EUROPE     183

11.3.2    GERMANY         183

11.3.2.1 Rising disposable incomes to boost use of body contouring devices          183

11.3.3    UK         187

11.3.3.1 Reduced stigma for body contouring procedures to drive market growth  187

11.3.4    FRANCE             190

11.3.4.1 Improved standard of living and growing disposable income to support market growth   190

11.3.5    ITALY   194

11.3.5.1 Increasing number of plastic surgeons to favor market growth   194

11.3.6    SPAIN   197

11.3.6.1 Increasing demand for cosmetic procedures and rising availability of safe minimally invasive technology to fuel growth 197

11.3.7    REST OF EUROPE           201

11.4       ASIA PACIFIC    204

11.4.1    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC          210

11.4.2    CHINA  211

11.4.2.1 Growing availability of body contouring surgery to drive market 211

11.4.3    JAPAN  214

11.4.3.1 Increasing number of plastic surgeons to propel market growth in Japan  214

11.4.4    INDIA   218

11.4.4.1 Increasing disposable incomes to drive market growth in India   218

11.4.5    REST OF ASIA PACIFIC  221

11.5       LATIN AMERICA             225

11.5.1    MACROECONOMIC OUTLOOK FOR LATIN AMERICA     229

11.5.2    BRAZIL 230

11.5.2.1 Growing focus on medical tourism to drive market growth         230

11.5.3    MEXICO             233

11.5.3.1 Growing volume of surgical procedures to aid market growth     233

11.5.4    REST OF LATIN AMERICA          237

11.6       MIDDLE EAST & AFRICA             240

11.6.1    IMPLEMENTATION OF FAVORABLE INITIATIVES TO BOOST MARKET              240

11.6.2    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA     244

11.7       GCC COUNTRIES           244

11.7.1    HIGHER DISPOSABLE INCOMES TO SUPPORT MARKET GROWTH              244

11.7.2    MACROECONOMIC OUTLOOK FOR GCC COUNTRIES    248

12          COMPETITIVE LANDSCAPE       249

12.1       OVERVIEW        249

12.2       KEY PLAYER STRATEGY/RIGHT TO WIN             249

12.2.1    OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN BODY CONTOURING DEVICES MARKET          249

12.3       REVENUE ANALYSIS, 2019–2023 251

12.4       MARKET SHARE ANALYSIS, 2023             251

12.5       COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023   253

12.5.1    LIST OF EVALUATED VENDORS             253

12.5.2    STARS  253

12.5.3    EMERGING LEADERS    253

12.5.4    PERVASIVE PLAYERS     253

12.5.5    PARTICIPANTS 253

12.5.6    COMPANY FOOTPRINT: KEY PLAYERS, 2023      255

12.5.6.1 Company footprint            255

12.5.6.2 Type footprint     255

12.5.6.3 Application footprint         256

12.5.6.4 Region footprint  256

12.6       COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023         257

12.6.1    PROGRESSIVE COMPANIES       257

12.6.2    RESPONSIVE COMPANIES          257

12.6.3    DYNAMIC COMPANIES 257

12.6.4    STARTING BLOCKS       257

12.6.5    COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023           258

12.7       COMPANY VALUATION & FINANCIAL METRICS 259

12.7.1    FINANCIAL METRICS    259

12.7.2    COMPANY VALUATION 260

12.8       BRAND/PRODUCT COMPARISON          261

12.8.1    ABBVIE, INC.     262

12.8.2    CYNOSURE LUTRONIC 262

12.8.3    CUTERA             262

12.9       COMPETITIVE SCENARIO          262

12.9.1    PRODUCT LAUNCHES & APPROVALS    262

12.9.2    DEALS  263

13          COMPANY PROFILES    264

13.1       KEY PLAYERS   264

13.1.1    ABBVIE, INC.     264

13.1.1.1 Business overview 264

13.1.1.2 Products offered  265

13.1.1.3 Recent developments         266

13.1.1.3.1            Product launches & approvals          266

13.1.1.3.2            Deals     267

13.1.1.4 MnM view           267

13.1.1.4.1            Right to win         267

13.1.1.4.2            Strategic choices  267

13.1.1.4.3            Weaknesses & competitive threats   267

13.1.2    INMODE LTD.   268

13.1.2.1 Business overview 268

13.1.2.2 Products offered  269

13.1.2.3 MnM view           270

13.1.2.3.1            Right to win         270

13.1.2.3.2            Strategic choices  270

13.1.2.3.3            Weaknesses & competitive threats   270

13.1.3    BAUSCH HEALTH COMPANIES INC.       271

13.1.3.1 Business overview 271

13.1.3.2 Products offered  272

13.1.3.3 Recent developments         273

13.1.3.3.1            Product approvals 273

13.1.3.4 MnM view           273

13.1.3.4.1            Right to win         273

13.1.3.4.2            Strategic choices  273

13.1.3.4.3            Weaknesses & competitive threats   273

13.1.4    CYNOSURE LUTRONIC 274

13.1.4.1 Business overview 274

13.1.4.2 Products offered  275

13.1.4.3 MnM view           276

13.1.4.3.1            Right to win         276

13.1.4.3.2            Strategic choices  276

13.1.4.3.3            Weaknesses & competitive threats   276

13.1.5    CUTERA, INC.   277

13.1.5.1 Business overview 277

13.1.5.2 Products offered  278

13.1.5.3 Recent developments         279

13.1.5.3.1            Product launches 279

13.1.5.4 MnM view           279

13.1.5.4.1            Right to win         279

13.1.5.4.2            Strategic choices  279

13.1.5.4.3            Weaknesses & competitive threats   279

13.1.6    VENUS CONCEPT          280

13.1.6.1 Business overview 280

13.1.6.2 Products offered  281

13.1.6.3 Recent developments         282

13.1.6.3.1            Product launches & approvals          282

13.1.7    ENDYMED MEDICAL     283

13.1.7.1 Business overview 283

13.1.7.2 Products offered  283

13.1.8    LUMENIS BE LTD.          284

13.1.8.1 Business overview 284

13.1.8.2 Products offered  284

13.1.9    ALMA LASERS   285

13.1.9.1 Business overview 285

13.1.9.2 Products offered  285

13.1.10  CANDELA CORPORATION         287

13.1.10.1             Business overview 287

13.1.10.2             Products offered  287

13.1.10.3             Recent developments         288

13.1.10.3.1          Product launches 288

13.2       OTHER PLAYERS           289

13.2.1    BTL AESTHETICS LTD. 289

13.2.2    MICROAIRE SURGICAL INSTRUMENTS, LLC       290

13.2.3    FOTONA            291

13.2.4    NOUVAG AG     292

13.2.5    ERCHONIA CORPORATION       292

13.2.6    KONMISON       293

13.2.7    SKINNOVATION PVT. LTD.        294

13.2.8    3D AESTHETICS             295

13.2.9    ZIMMER MEDIZINSYSTEME GMBH        296

13.2.10  ROHRER AESTHETICS   297

13.2.11  SKIN AESTHETICS         297

13.2.12  SHARPLIGHT TECHNOLOGIES INC.       298

13.2.13  SEBBIN 299

13.2.14  DEKA M.E.L.A. S.R.L.      300

13.2.15  INDIBA 301

14          APPENDIX         302

14.1       DISCUSSION GUIDE      302

14.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             306

14.3       CUSTOMIZATION OPTIONS      308

14.4       RELATED REPORTS       308

14.5       AUTHOR DETAILS         309

LIST OF TABLES

TABLE 1             RISK ASSESSMENT: BODY CONTOURING DEVICES MARKET              44

TABLE 2             NUMBER OF PROCEDURES (2022 VS. 2023)         56

TABLE 3             NUMBER OF PROCEDURES (2019 VS. 2022)         57

TABLE 4             NUMBER OF PROCEDURES IN MALES (2022)      58

TABLE 5             AESTHETIC PLASTIC SURGEON FEES FOR BODY CONTOURING PROCEDURES    60

TABLE 6             INDICATIVE PRICING FOR BODY CONTOURING DEVICES (2024)   62

TABLE 7             AVERAGE SELLING PRICE OF BODY CONTOURING DEVICES, BY REGION/COUNTRY (2022 VS. 2023 VS. 2024)  63

TABLE 8             IMPORT DATA FOR LASER AESTHETIC DEVICES, BY COUNTRY,

2019–2023 (USD MILLION)          69

TABLE 9             EXPORT DATA FOR LASER AESTHETIC DEVICES, BY COUNTRY,

2019–2023 (USD MILLION)          69

TABLE 10           BODY CONTOURING DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS         72

TABLE 11           NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         74

TABLE 12           EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 74

TABLE 13           ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 75

TABLE 14           US FDA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              76

TABLE 15           CHINA: CLASSIFICATION OF MEDICAL DEVICES             77

TABLE 16           BODY CONTOURING DEVICES MARKET: DETAILED LIST OF CONFERENCES & EVENTS          81

TABLE 17           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BODY CONTOURING DEVICES FOR END USERS (%)       83

TABLE 18           KEY BUYING CRITERIA OF BODY CONTOURING DEVICES FOR END USERS       84

TABLE 19           BODY CONTOURING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 87

TABLE 20           NON-INVASIVE BODY CONTOURING DEVICES AND TECHNOLOGIES            88

TABLE 21           NON-INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          88

TABLE 22           NON-INVASIVE BODY CONTOURING DEVICES MARKET, BY REGION,

2022–2029 (USD MILLION)          89

TABLE 23           NORTH AMERICA: NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            89

TABLE 24           EUROPE: NON-INVASIVE BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         90

TABLE 25           ASIA PACIFIC: NON-INVASIVE BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         90

TABLE 26           LATIN AMERICA: NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            91

TABLE 27           KEY RADIOFREQUENCY (RF) BODY CONTOURING DEVICES AVAILABLE IN MARKET 91

TABLE 28           RADIOFREQUENCY (RF) BODY CONTOURING DEVICES MARKET, BY REGION,

2022–2029 (USD MILLION)          92

TABLE 29           NORTH AMERICA: RADIOFREQUENCY (RF) BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              92

TABLE 30           EUROPE: RADIOFREQUENCY (RF) BODY CONTOURING DEVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            93

TABLE 31           ASIA PACIFIC: RADIOFREQUENCY (RF) BODY CONTOURING DEVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            93

TABLE 32           LATIN AMERICA: RADIOFREQUENCY (RF) BODY CONTOURING DEVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            94

TABLE 33           KEY CRYOLIPOLYSIS/FAT FREEZING BODY CONTOURING DEVICES AVAILABLE IN MARKET           94

TABLE 34           CRYOLIPOLYSIS/FAT FREEZING BODY CONTOURING DEVICES MARKET,

BY REGION, 2022–2029 (USD MILLION)  95

TABLE 35           NORTH AMERICA: CRYOLIPOLYSIS/FAT FREEZING BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              95

TABLE 36           EUROPE: CRYOLIPOLYSIS/FAT FREEZING BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              96

TABLE 37           ASIA PACIFIC: CRYOLIPOLYSIS/FAT FREEZING BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              96

TABLE 38           LATIN AMERICA: CRYOLIPOLYSIS/FAT FREEZING BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              97

TABLE 39           KEY HIGH-INTENSITY-FOCUSED ULTRASOUND (HIFU) BODY CONTOURING DEVICES AVAILABLE IN MARKET            97

TABLE 40           HIGH-INTENSITY-FOCUSED ULTRASOUND (HIFU) BODY CONTOURING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)              98

TABLE 41           NORTH AMERICA: HIGH-INTENSITY-FOCUSED ULTRASOUND (HIFU) BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          98

TABLE 42           EUROPE: HIGH-INTENSITY-FOCUSED ULTRASOUND (HIFU) BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          99

TABLE 43           ASIA PACIFIC: HIGH-INTENSITY-FOCUSED ULTRASOUND (HIFU) BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          99

TABLE 44           LATIN AMERICA: HIGH-INTENSITY-FOCUSED ULTRASOUND (HIFU) BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          100

TABLE 45           KEY LOW-LEVEL LASER THERAPY (LLLT) BODY CONTOURING DEVICES

AVAILABLE IN MARKET 101

TABLE 46           LOW-LEVEL LASER THERAPY (LLLT) BODY CONTOURING DEVICES MARKET,

BY REGION, 2022–2029 (USD MILLION)  101

TABLE 47           NORTH AMERICA: LOW-LEVEL LASER THERAPY (LLLT) BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              102

TABLE 48           EUROPE: LOW-LEVEL LASER THERAPY (LLLT) BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              102

TABLE 49           ASIA PACIFIC: LOW-LEVEL LASER THERAPY (LLLT) BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              103

TABLE 50           LATIN AMERICA: LOW-LEVEL LASER THERAPY (LLLT) BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              103

TABLE 51           OTHER NON-INVASIVE BODY CONTOURING DEVICES MARKET, BY REGION,

2022–2029 (USD MILLION)          104

TABLE 52           NORTH AMERICA: OTHER NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            104

TABLE 53           EUROPE: OTHER NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            105

TABLE 54           ASIA PACIFIC: OTHER NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            105

TABLE 55           LATIN AMERICA: OTHER NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            106

TABLE 56           INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          107

TABLE 57           INVASIVE BODY CONTOURING DEVICES MARKET, BY REGION,

2022–2029 (USD MILLION)          107

TABLE 58           NORTH AMERICA: INVASIVE BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         108

TABLE 59           EUROPE: INVASIVE BODY CONTOURING DEVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          108

TABLE 60           ASIA PACIFIC: INVASIVE BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         109

TABLE 61           LATIN AMERICA: INVASIVE BODY CONTOURING DEVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            109

TABLE 62           TOP 5 COUNTRIES PERFORMING LIPOSUCTION TREATMENTS (2018–2022)       110

TABLE 63           KEY LIPOSUCTION BODY CONTOURING DEVICES AVAILABLE IN MARKET       110

TABLE 64           LIPOSUCTION BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (THOUSAND PROCEDURES) 111

TABLE 65           LIPOSUCTION BODY CONTOURING DEVICES MARKET, BY REGION,

2022–2029 (USD MILLION)          111

TABLE 66           NORTH AMERICA: LIPOSUCTION BODY CONTOURING DEVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            112

TABLE 67           EUROPE: LIPOSUCTION BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         112

TABLE 68           ASIA PACIFIC: LIPOSUCTION BODY CONTOURING DEVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            113

TABLE 69           LATIN AMERICA: LIPOSUCTION BODY CONTOURING DEVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            113

TABLE 70           KEY LASER-ASSISTED BODY CONTOURING DEVICES AVAILABLE IN MARKET 114

TABLE 71           LASER-ASSISTED BODY CONTOURING DEVICES MARKET, BY REGION,

2022–2029 (USD MILLION)          115

TABLE 72           NORTH AMERICA: LASER-ASSISTED BODY CONTOURING DEVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            115

TABLE 73           EUROPE: LASER-ASSISTED BODY CONTOURING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         116

TABLE 74           ASIA PACIFIC: LASER-ASSISTED BODY CONTOURING DEVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            116

TABLE 75           LATIN AMERICA: LASER-ASSISTED BODY CONTOURING DEVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            117

TABLE 76           KEY BODY CONTOURING IMPLANTS/FILLERS AVAILABLE IN MARKET            117

TABLE 77           BODY CONTOURING IMPLANTS/FILLERS MARKET, BY REGION,

2022–2029 (USD MILLION)          118

TABLE 78           NORTH AMERICA: BODY CONTOURING IMPLANTS/FILLERS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            118

TABLE 79           EUROPE: BODY CONTOURING IMPLANTS/FILLERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          119

TABLE 80           ASIA PACIFIC: BODY CONTOURING IMPLANTS/FILLERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         119

TABLE 81           LATIN AMERICA: BODY CONTOURING IMPLANTS/FILLERS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            120

TABLE 82           BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          122

TABLE 83           TOP 5 COUNTRIES PERFORMING NON-SURGICAL FAT REDUCTION TREATMENTS (2018–2022) 123

TABLE 84           BODY CONTOURING DEVICES MARKET FOR FAT REDUCTION APPLICATIONS,

BY REGION, 2022–2029 (USD MILLION)  123

TABLE 85           NORTH AMERICA: BODY CONTOURING DEVICES MARKET FOR FAT REDUCTION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)              124

TABLE 86           EUROPE: BODY CONTOURING DEVICES MARKET FOR FAT REDUCTION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)  124

TABLE 87           ASIA PACIFIC: BODY CONTOURING DEVICES MARKET FOR FAT REDUCTION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)              125

TABLE 88           LATIN AMERICA: BODY CONTOURING DEVICES MARKET FOR FAT REDUCTION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)              125

TABLE 89           BODY CONTOURING DEVICES MARKET FOR SKIN TIGHTENING APPLICATIONS,

BY REGION, 2022–2029 (USD MILLION)  126

TABLE 90           NORTH AMERICA: BODY CONTOURING DEVICES MARKET FOR SKIN TIGHTENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          126

TABLE 91           EUROPE: BODY CONTOURING DEVICES MARKET FOR SKIN TIGHTENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 127

TABLE 92           ASIA PACIFIC: BODY CONTOURING DEVICES MARKET FOR SKIN TIGHTENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)              127

TABLE 93           LATIN AMERICA: BODY CONTOURING DEVICES MARKET FOR SKIN TIGHTENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)              128

TABLE 94           BODY CONTOURING DEVICES MARKET FOR BODY TONING & SCULPTING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)       129

TABLE 95           NORTH AMERICA: BODY CONTOURING DEVICES MARKET FOR BODY TONING & SCULPTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 129

TABLE 96           EUROPE: BODY CONTOURING DEVICES MARKET FOR BODY TONING & SCULPTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          130

TABLE 97           ASIA PACIFIC: BODY CONTOURING DEVICES MARKET FOR BODY TONING & SCULPTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          130

TABLE 98           LATIN AMERICA: BODY CONTOURING DEVICES MARKET FOR BODY TONING & SCULPTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          131

TABLE 99           NO. OF CELLULITE TREATMENTS PERFORMED (2022)  131

TABLE 100         BODY CONTOURING DEVICES MARKET FOR CELLULITE TREATMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)     132

TABLE 101         NORTH AMERICA: BODY CONTOURING DEVICES MARKET FOR CELLULITE TREATMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          133

TABLE 102         EUROPE: BODY CONTOURING DEVICES MARKET FOR CELLULITE TREATMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          133

TABLE 103         ASIA PACIFIC: BODY CONTOURING DEVICES MARKET FOR CELLULITE TREATMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          134

TABLE 104         LATIN AMERICA: BODY CONTOURING DEVICES MARKET FOR CELLULITE TREATMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          134

TABLE 105         BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          136

TABLE 106         BODY CONTOURING DEVICES MARKET FOR INDIVIDUALS BETWEEN

35 TO 50 YEARS, BY REGION, 2022–2029 (USD MILLION) 137

TABLE 107         NORTH AMERICA: BODY CONTOURING DEVICES MARKET FOR INDIVIDUALS BETWEEN 35 TO 50 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)          137

TABLE 108         EUROPE: BODY CONTOURING DEVICES MARKET FOR INDIVIDUALS

BETWEEN 35 TO 50 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)      138

TABLE 109         ASIA PACIFIC: BODY CONTOURING DEVICES MARKET FOR INDIVIDUALS BETWEEN 35 TO 50 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)          138

TABLE 110         LATIN AMERICA: BODY CONTOURING DEVICES MARKET FOR INDIVIDUALS BETWEEN 35 TO 50 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)          139

TABLE 111         BODY CONTOURING DEVICES MARKET FOR INDIVIDUALS ABOVE 50 YEARS,

BY REGION, 2022–2029 (USD MILLION)  140

TABLE 112         NORTH AMERICA: BODY CONTOURING DEVICES MARKET FOR INDIVIDUALS ABOVE 50 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)              140

TABLE 113         EUROPE: BODY CONTOURING DEVICES MARKET FOR INDIVIDUALS

ABOVE 50 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)        141

TABLE 114         ASIA PACIFIC: BODY CONTOURING DEVICES MARKET FOR INDIVIDUALS

ABOVE 50 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)        141

TABLE 115         LATIN AMERICA: BODY CONTOURING DEVICES MARKET FOR INDIVIDUALS

ABOVE 50 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)        142

TABLE 116         BODY CONTOURING DEVICES MARKET FOR INDIVIDUALS BELOW 35 YEARS,

BY REGION, 2022–2029 (USD MILLION)  143

TABLE 117         NORTH AMERICA: BODY CONTOURING DEVICES MARKET FOR INDIVIDUALS BELOW 35 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)              143

TABLE 118         EUROPE: BODY CONTOURING DEVICES MARKET FOR INDIVIDUALS

BELOW 35 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)        144

TABLE 119         ASIA PACIFIC: BODY CONTOURING DEVICES MARKET FOR INDIVIDUALS

BELOW 35 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)        144

TABLE 120         LATIN AMERICA: BODY CONTOURING DEVICES MARKET FOR INDIVIDUALS

BELOW 35 YEARS, BY COUNTRY, 2022–2029 (USD MILLION)        145

TABLE 121         BODY CONTOURING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)     147

TABLE 122         BODY CONTOURING PROCEDURES IN WOMEN (2022)  148

TABLE 123         BODY CONTOURING DEVICES MARKET FOR WOMEN, BY REGION,

2022–2029 (USD MILLION)          148

TABLE 124         NORTH AMERICA: BODY CONTOURING DEVICES MARKET FOR WOMEN,

BY COUNTRY, 2022–2029 (USD MILLION)            149

TABLE 125        EUROPE: BODY CONTOURING DEVICES MARKET FOR WOMEN,

BY COUNTRY, 2022–2029 (USD MILLION)            149

TABLE 126         ASIA PACIFIC: BODY CONTOURING DEVICES MARKET FOR WOMEN,

BY COUNTRY, 2022–2029 (USD MILLION)            150

TABLE 127         LATIN AMERICA: BODY CONTOURING DEVICES MARKET FOR WOMEN,

BY COUNTRY, 2022–2029 (USD MILLION)            150

TABLE 128         BODY CONTOURING PROCEDURES IN MEN (2022)        151

TABLE 129         BODY CONTOURING DEVICES MARKET FOR MEN, BY REGION,

2022–2029 (USD MILLION)          151

TABLE 130         NORTH AMERICA: BODY CONTOURING DEVICES MARKET FOR MEN,

BY COUNTRY, 2022–2029 (USD MILLION)            152

TABLE 131         EUROPE: BODY CONTOURING DEVICES MARKET FOR MEN, BY COUNTRY,

2022–2029 (USD MILLION)          152

TABLE 132         ASIA PACIFIC: BODY CONTOURING DEVICES MARKET FOR MEN, BY COUNTRY, 2022–2029 (USD MILLION)  153

TABLE 133         LATIN AMERICA: BODY CONTOURING DEVICES MARKET FOR MEN, BY COUNTRY, 2022–2029 (USD MILLION)  153

TABLE 134         BODY CONTOURING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)     155

TABLE 135         BODY CONTOURING DEVICES MARKET FOR SPECIALTY CLINICS, BY REGION, 2022–2029 (USD MILLION)             156

TABLE 136         NORTH AMERICA: BODY CONTOURING DEVICES MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)        156

TABLE 137         EUROPE: BODY CONTOURING DEVICES MARKET FOR SPECIALTY CLINICS,

BY COUNTRY, 2022–2029 (USD MILLION)            157

TABLE 138         ASIA PACIFIC: BODY CONTOURING DEVICES MARKET FOR SPECIALTY CLINICS,

BY COUNTRY, 2022–2029 (USD MILLION)            157

TABLE 139         LATIN AMERICA: BODY CONTOURING DEVICES MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)   158

TABLE 140         BODY CONTOURING DEVICES MARKET FOR MEDICAL SPAS & BEAUTY CENTERS, BY REGION, 2022–2029 (USD MILLION)         159

TABLE 141         NORTH AMERICA: BODY CONTOURING DEVICES MARKET FOR MEDICAL SPAS & BEAUTY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)          159

TABLE 142         EUROPE: BODY CONTOURING DEVICES MARKET FOR MEDICAL SPAS & BEAUTY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)              160

TABLE 143         ASIA PACIFIC: BODY CONTOURING DEVICES MARKET FOR MEDICAL SPAS & BEAUTY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)              160

TABLE 144         LATIN AMERICA: BODY CONTOURING DEVICES MARKET FOR MEDICAL SPAS & BEAUTY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)              161

TABLE 145         BODY CONTOURING DEVICES MARKET FOR HOSPITALS, BY REGION,

2022–2029 (USD MILLION)          162

TABLE 146         NORTH AMERICA: BODY CONTOURING DEVICES MARKET FOR HOSPITALS,

BY COUNTRY, 2022–2029 (USD MILLION)            162

TABLE 147         EUROPE: BODY CONTOURING DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)    163

TABLE 148         ASIA PACIFIC: BODY CONTOURING DEVICES MARKET FOR HOSPITALS,

BY COUNTRY, 2022–2029 (USD MILLION)            163

TABLE 149         LATIN AMERICA: BODY CONTOURING DEVICES MARKET FOR HOSPITALS,

BY COUNTRY, 2022–2029 (USD MILLION)            164

TABLE 150         BODY CONTOURING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 166

TABLE 151         NORTH AMERICA: BODY CONTOURING DEVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          168

TABLE 152         NORTH AMERICA: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          168

TABLE 153         NORTH AMERICA: NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       169

TABLE 154         NORTH AMERICA: INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       169

TABLE 155         NORTH AMERICA: BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          170

TABLE 156         NORTH AMERICA: BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          170

TABLE 157         NORTH AMERICA: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          170

TABLE 158         NORTH AMERICA: BODY CONTOURING DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          171

TABLE 159         NORTH AMERICA: MACROECONOMIC INDICATORS      171

TABLE 160         US: NO. OF BODY CONTOURING PROCEDURES (2018 VS. 2020 VS. 2022)            173

TABLE 161         US: BODY CONTOURING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)     173

TABLE 162         US: NON-INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          173

TABLE 163        US: INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          174

TABLE 164         US: BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          174

TABLE 165         US: BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          174

TABLE 166         US: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          175

TABLE 167         US: BODY CONTOURING DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          175

TABLE 168         CANADA: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          176

TABLE 169         CANADA: NON-INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          176

TABLE 170         CANADA: INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          177

TABLE 171         CANADA: BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          177

TABLE 172         CANADA: BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          178

TABLE 173        CANADA: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          178

TABLE 174         CANADA: BODY CONTOURING DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          178

TABLE 175         EUROPE: BODY CONTOURING DEVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          179

TABLE 176         EUROPE: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          180

TABLE 177         EUROPE: NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       180

TABLE 178         EUROPE: INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          181

TABLE 179         EUROPE: BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          181

TABLE 180         EUROPE: BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          182

TABLE 181         EUROPE: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          182

TABLE 182         EUROPE: BODY CONTOURING DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          182

TABLE 183         EUROPE: MACROECONOMIC INDICATORS        183

TABLE 184         GERMANY: NO. OF BODY CONTOURING PROCEDURES (2018 VS. 2020 VS. 2022)           184

TABLE 185         GERMANY: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          184

TABLE 186         GERMANY: NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       184

TABLE 187         GERMANY: INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       185

TABLE 188         GERMANY: BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          185

TABLE 189         GERMANY: BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          186

TABLE 190         GERMANY: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          186

TABLE 191         GERMANY: BODY CONTOURING DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          186

TABLE 192         UK: BODY CONTOURING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)     187

TABLE 193         UK: NON-INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          188

TABLE 194         UK: INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          188

TABLE 195         UK: BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          189

TABLE 196         UK: BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          189

TABLE 197         UK: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          189

TABLE 198         UK: BODY CONTOURING DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          190

TABLE 199         FRANCE: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          191

TABLE 200         FRANCE: NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       191

TABLE 201         FRANCE: INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          192

TABLE 202         FRANCE: BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          192

TABLE 203         FRANCE: BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          193

TABLE 204         FRANCE: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          193

TABLE 205         FRANCE: BODY CONTOURING DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          193

TABLE 206         ITALY: NO. OF BODY CONTOURING PROCEDURES (2018 VS. 2020 VS. 2022)    194

TABLE 207         ITALY: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          194

TABLE 208        ITALY: NON-INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          195

TABLE 209         ITALY: INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          195

TABLE 210         ITALY: BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          196

TABLE 211         ITALY: BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          196

TABLE 212         ITALY: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          196

TABLE 213         ITALY: BODY CONTOURING DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          197

TABLE 214         SPAIN: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          198

TABLE 215        SPAIN: NON-INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          198

TABLE 216         SPAIN: INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          199

TABLE 217         SPAIN: BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          199

TABLE 218         SPAIN: BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          200

TABLE 219         SPAIN: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          200

TABLE 220         SPAIN: BODY CONTOURING DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          200

TABLE 221         REST OF EUROPE: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          201

TABLE 222         REST OF EUROPE: NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       202

TABLE 223         REST OF EUROPE: INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       202

TABLE 224         REST OF EUROPE: BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          203

TABLE 225         REST OF EUROPE: BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          203

TABLE 226         REST OF EUROPE: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          203

TABLE 227         REST OF EUROPE: BODY CONTOURING DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          204

TABLE 228         ASIA PACIFIC: NO. OF BODY CONTOURING PROCEDURES, BY COUNTRY, 2022 205

TABLE 229         ASIA PACIFIC: BODY CONTOURING DEVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          207

TABLE 230         ASIA PACIFIC: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)        207

TABLE 231         ASIA PACIFIC: NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)     208

TABLE 232         ASIA PACIFIC: INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          208

TABLE 233         ASIA PACIFIC: BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          209

TABLE 234         ASIA PACIFIC: BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          209

TABLE 235         ASIA PACIFIC: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          209

TABLE 236         ASIA PACIFIC: BODY CONTOURING DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          210

TABLE 237         ASIA PACIFIC: MACROECONOMIC INDICATORS             210

TABLE 238         CHINA: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          211

TABLE 239         CHINA: NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       212

TABLE 240         CHINA: INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          212

TABLE 241         CHINA: BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          213

TABLE 242         CHINA: BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          213

TABLE 243         CHINA: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          213

TABLE 244         CHINA: BODY CONTOURING DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          214

TABLE 245         JAPAN: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          215

TABLE 246        JAPAN: NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       215

TABLE 247         JAPAN: INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          216

TABLE 248         JAPAN: BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          216

TABLE 249         JAPAN: BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          217

TABLE 250         JAPAN: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          217

TABLE 251         JAPAN: BODY CONTOURING DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          217

TABLE 252         INDIA: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          218

TABLE 253        INDIA: NON-INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          219

TABLE 254         INDIA: INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          219

TABLE 255         INDIA: BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          220

TABLE 256         INDIA: BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          220

TABLE 257         INDIA: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          220

TABLE 258         INDIA: BODY CONTOURING DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          221

TABLE 259        REST OF ASIA PACIFIC: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          222

TABLE 260         REST OF ASIA PACIFIC: NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       222

TABLE 261         REST OF ASIA PACIFIC: INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       223

TABLE 262        REST OF ASIA PACIFIC: BODY CONTOURING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     223

TABLE 263        REST OF ASIA PACIFIC: BODY CONTOURING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)         224

TABLE 264        REST OF ASIA PACIFIC: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          224

TABLE 265        REST OF ASIA PACIFIC: BODY CONTOURING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)            224

TABLE 266         COST OF AESTHETIC PROCEDURES IN US VS. LATIN AMERICAN COUNTRIES,

AS OF 2022 (USD)           225

TABLE 267         LATIN AMERICA: BODY CONTOURING DEVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          226

TABLE 268         LATIN AMERICA: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          226

TABLE 269         LATIN AMERICA: NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       227

TABLE 270         LATIN AMERICA: INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          227

TABLE 271         LATIN AMERICA: BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          228

TABLE 272         LATIN AMERICA: BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          228

TABLE 273         LATIN AMERICA: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          228

TABLE 274         LATIN AMERICA: BODY CONTOURING DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          229

TABLE 275         LATIN AMERICA & CARIBBEAN: MACROECONOMIC INDICATORS     229

TABLE 276         BRAZIL: NO. OF BODY CONTOURING PROCEDURES (2022)              230

TABLE 277         BRAZIL: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          230

TABLE 278         BRAZIL: NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       231

TABLE 279         BRAZIL: INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          231

TABLE 280         BRAZIL: BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          232

TABLE 281         BRAZIL: BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          232

TABLE 282         BRAZIL: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          232

TABLE 283        BRAZIL: BODY CONTOURING DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          233

TABLE 284         MEXICO: NO. OF BODY CONTOURING PROCEDURES (2022)              234

TABLE 285         MEXICO: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          234

TABLE 286         MEXICO: NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       235

TABLE 287         MEXICO: INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          235

TABLE 288         MEXICO: BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          236

TABLE 289         MEXICO: BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          236

TABLE 290         MEXICO: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          236

TABLE 291         MEXICO: BODY CONTOURING DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          237

TABLE 292         REST OF LATIN AMERICA: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          237

TABLE 293         REST OF LATIN AMERICA: NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       238

TABLE 294         REST OF LATIN AMERICA: INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       238

TABLE 295         REST OF LATIN AMERICA: BODY CONTOURING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  239

TABLE 296         REST OF LATIN AMERICA: BODY CONTOURING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)     239

TABLE 297         REST OF LATIN AMERICA: BODY CONTOURING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)           239

TABLE 298         REST OF LATIN AMERICA: BODY CONTOURING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)         240

TABLE 299         MIDDLE EAST & AFRICA: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          241

TABLE 300         MIDDLE EAST & AFRICA: NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       241

TABLE 301         MIDDLE EAST & AFRICA: INVASIVE BODY CONTOURING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 242

TABLE 302         MIDDLE EAST & AFRICA: BODY CONTOURING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  242

TABLE 303         MIDDLE EAST & AFRICA: BODY CONTOURING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)     243

TABLE 304         MIDDLE EAST & AFRICA: BODY CONTOURING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)           243

TABLE 305         MIDDLE EAST & AFRICA: BODY CONTOURING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)         243

TABLE 306         MIDDLE EAST & NORTH AFRICA: MACROECONOMIC INDICATORS     244

TABLE 307         GCC COUNTRIES: BODY CONTOURING DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          245

TABLE 308         GCC COUNTRIES: NON-INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       245

TABLE 309         GCC COUNTRIES: INVASIVE BODY CONTOURING DEVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       246

TABLE 310         GCC COUNTRIES: BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          246

TABLE 311         GCC COUNTRIES: BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2022–2029 (USD MILLION)          247

TABLE 312         GCC COUNTRIES: BODY CONTOURING DEVICES MARKET, BY GENDER,

2022–2029 (USD MILLION)          247

TABLE 313         GCC COUNTRIES: BODY CONTOURING DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          247

TABLE 314         GCC COUNTRIES: MACROECONOMIC INDICATORS       248

TABLE 315         BODY CONTOURING DEVICES MARKET: STRATEGIES ADOPTED         249

TABLE 316         BODY CONTOURING DEVICES MARKET: DEGREE OF COMPETITION 252

TABLE 317         BODY CONTOURING DEVICES MARKET: TYPE FOOTPRINT              255

TABLE 318         BODY CONTOURING DEVICES MARKET: APPLICATION FOOTPRINT      256

TABLE 319         BODY CONTOURING DEVICES MARKET: REGION FOOTPRINT              256

TABLE 320         BODY CONTOURING DEVICES MARKET: DETAILED LIST OF KEY START-UPS/SMES  258

TABLE 321         BODY CONTOURING DEVICES MARKET: COMPETITIVE BENCHMARKING

OF START-UPS/SMES    259

TABLE 322         BODY CONTOURING DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2024             262

TABLE 323         BODY CONTOURING DEVICES MARKET: DEALS, JANUARY 2021–AUGUST 2024        263

TABLE 324         ABBVIE, INC.: COMPANY OVERVIEW     264

TABLE 325         ABBVIE, INC.: PRODUCTS OFFERED      265

TABLE 326         ABBVIE, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JULY 2024 266

TABLE 327         ABBVIE, INC.: DEALS, JANUARY 2021–MARCH 2024          267

TABLE 328         INMODE LTD.: COMPANY OVERVIEW   268

TABLE 329         INMODE LTD.: PRODUCTS OFFERED    269

TABLE 330         BAUSCH HEALTH COMPANIES INC.: COMPANY OVERVIEW              271

TABLE 331         BAUSCH HEALTH COMPANIES INC.: PRODUCTS OFFERED              272

TABLE 332         BAUSCH HEALTH COMPANIES INC.: PRODUCT APPROVALS,

JANUARY 2021–JULY 2024           273

TABLE 333         CYNOSURE LUTRONIC: COMPANY OVERVIEW  274

TABLE 334         CYNOSURE LUTRONIC: PRODUCTS OFFERED   275

TABLE 335         CUTERA, INC.: COMPANY OVERVIEW    277

TABLE 336         CUTERA, INC.: PRODUCTS OFFERED     278

TABLE 337         CUTERA, INC.: PRODUCT LAUNCHES, JANUARY 2021–JULY 2024              279

TABLE 338         VENUS CONCEPT: COMPANY OVERVIEW           280

TABLE 339         VENUS CONCEPT: PRODUCTS OFFERED            281

TABLE 340         VENUS CONCEPT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JULY 2024           282

TABLE 341         ENDYMED MEDICAL: COMPANY OVERVIEW     283

TABLE 342         ENDYMED MEDICAL: PRODUCTS OFFERED      283

TABLE 343         LUMENIS BE LTD.: COMPANY OVERVIEW          284

TABLE 344         LUMENIS BE LTD.: PRODUCTS OFFERED           284

TABLE 345         ALMA LASERS: COMPANY OVERVIEW   285

TABLE 346         ALMA LASERS: PRODUCTS OFFERED    285

TABLE 347         CANDELA CORPORATION: COMPANY OVERVIEW          287

TABLE 348         CANDELA CORPORATION: PRODUCTS OFFERED           287

TABLE 349         CANDELA CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JULY 2024 288

LIST OF FIGURES

FIGURE 1           BODY CONTOURING DEVICES MARKET: RESEARCH DESIGN METHODOLOGY           33

FIGURE 2           BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 38

FIGURE 3           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,

AND REGION    38

FIGURE 4           BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH       39

FIGURE 5           CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   40

FIGURE 6           BODY CONTOURING DEVICES MARKET: TOP-DOWN APPROACH       41

FIGURE 7           DATA TRIANGULATION METHODOLOGY         42

FIGURE 8           BODY CONTOURING DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 45

FIGURE 9           BODY CONTOURING DEVICES MARKET, BY APPLICATION,

2024 VS. 2029 (USD MILLION)     46

FIGURE 10         BODY CONTOURING DEVICES MARKET, BY AGE GROUP,

2024 VS. 2029 (USD MILLION)     46

FIGURE 11         BODY CONTOURING DEVICES MARKET, BY GENDER,

2024 VS. 2029 (USD MILLION)     47

FIGURE 12         BODY CONTOURING DEVICES MARKET, BY END USER,

2024 VS. 2029 (USD MILLION)     48

FIGURE 13         BODY CONTOURING DEVICES MARKET: GEOGRAPHIC SNAPSHOT        49

FIGURE 14         GROWING AWARENESS OF BODY CONTOURING AND AESTHETIC PROCEDURES

TO DRIVE MARKET GROWTH   50

FIGURE 15         NON-INVASIVE DEVICES TO CONTINUE TO DOMINATE MARKET IN 2029             51

FIGURE 16         FAT REDUCTION APPLICATIONS TO DOMINATE MARKET DURING FORECAST PERIOD     51

FIGURE 17         MARKET FOR INDIVIDUALS BETWEEN 35 TO 50 YEARS TO ACCOUNT FOR LARGEST SHARE OF BODY CONTOURING MARKET DURING FORECAST PERIOD       52

FIGURE 18         BODY CONTOURING MARKET FOR WOMEN TO HOLD HIGHER SHARE OF OVERALL MARKET IN 2029    53

FIGURE 19         SPECIALTY CLINICS TO CONTINUE TO DOMINATE MARKET IN 2029      53

FIGURE 20         ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN BODY CONTOURING DEVICES MARKET DURING FORECAST PERIOD 54

FIGURE 21         BODY CONTOURING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES       55

FIGURE 22         PATENT ANALYSIS FOR BODY CONTOURING DEVICES (JANUARY 2014–

DECEMBER 2023)           65

FIGURE 23         VALUE CHAIN ANALYSIS OF BODY CONTOURING DEVICES: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASES              67

FIGURE 24         BODY CONTOURING DEVICES MARKET: SUPPLY CHAIN ANALYSIS          68

FIGURE 25         BODY CONTOURING DEVICES MARKET: ECOSYSTEM ANALYSIS          70

FIGURE 26         BODY CONTOURING DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS         72

FIGURE 27         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BODY CONTOURING DEVICES FOR END USERS 82

FIGURE 28         KEY BUYING CRITERIA OF BODY CONTOURING DEVICES FOR END USERS       84

FIGURE 29         BODY CONTOURING DEVICES MARKET: INVESTMENT & FUNDING SCENARIO     85

FIGURE 30         NORTH AMERICA: BODY CONTOURING DEVICES MARKET SNAPSHOT        167

FIGURE 31         ASIA PACIFIC: BODY CONTOURING DEVICES MARKET SNAPSHOT        206

FIGURE 32         REVENUE ANALYSIS OF KEY PLAYERS IN BODY CONTOURING DEVICES

MARKET (2019–2023)     251

FIGURE 33         MARKET SHARE ANALYSIS OF KEY PLAYERS IN BODY CONTOURING DEVICES MARKET (2023)             252

FIGURE 34         BODY CONTOURING DEVICES MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2023     254

FIGURE 35         BODY CONTOURING DEVICES MARKET: COMPANY FOOTPRINT      255

FIGURE 36         BODY CONTOURING DEVICES MARKET: COMPANY EVALUATION MATRIX

(START-UPS/SMES), 2023           258

FIGURE 37         EV/EBITDA OF KEY VENDORS   259

FIGURE 38         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY VENDORS             260

FIGURE 39         BODY CONTOURING DEVICES MARKET: PRODUCT/BRAND COMPARISON   261

FIGURE 40         ABBVIE, INC.: COMPANY SNAPSHOT (2023)        265

FIGURE 41         INMODE LTD.: COMPANY SNAPSHOT (2023)     269

FIGURE 42         BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT (2022)   272

FIGURE 43         CUTERA, INC.: COMPANY SNAPSHOT (2022)      278

FIGURE 44         VENUS CONCEPT: COMPANY SNAPSHOT (2023)             281

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧